Repligen Corporation (Nasdaq: RGEN) announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company’s proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read)…
Lees meer..

Tengion Inc. (Nasdaq: TNGN) announced that its scientists have presented new research data in three podium presentations at the 16th Annual Meeting of the International Society for Cellular Therapy (ISCT) which was held May 23-26 in Philadelphia…
Lees meer..

VIVUS, Inc. (Nasdaq: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010…
Lees meer..

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients…
Lees meer..

New York’s The Lung Cancer Research Foundation will donate $25,000 for studies at the Translational Genomics Research Institute as a result of its first Strides for Life event in Arizona.

Lees meer..

The Bill & Melinda Gates Foundation has donated $5 million to the Public Health Foundation of India for tobacco control efforts.

Lees meer..

The health insurer WellPoint has announced guidelines for using comparative effectiveness studies to pit drugs against one another and determine which works best, the Indianapolis Business Journal reports. “Congress has also approved $4.1 billion in the past 15 months to fund comparative-effectiveness studies and a new agency that specializes in them…
Lees meer..

A Florida State University College of Medicine researcher has discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma. The finding suggests a similar interaction could be occurring during the development of other types of cancer, leading to further understanding of how cancer works and how it might be stopped…
Lees meer..

The bacterium Helicobacter pylori, which lives in the human stomach and is associated with ulcers and gastric cancer, is shaped like a corkscrew, or helix. For years researchers have hypothesized that the bacterium’s twisty shape is what enables it to survive and thrive within the stomach’s acid-drenched environment, but until now they have had no proof…
Lees meer..

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We’re talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this…
Lees meer..